Concepedia

Maki Goda

MG

6

Publications

351

Citations

6

H-Index

2003

Active since

Affiliations

Mitsubishi Group (Japan)(Current)

Kyoto University

Mitsubishi Tanabe Pharma Corporation

Maki Goda is an author at Mitsubishi Group (Japan) specializing in bone metabolism, pain research, and cartilage degeneration.

Top concepts

Publications per year

2003–2018

6

Publications

6

Sodium Iodoacetate-Induced Experimental Osteoarthritis and Associated Pain Model in Rats

Kiyoshi Kobayashi, Rei Imaizumi, Hiroshi Sumichika et al. · Journal of Veterinary Medical Science · 2003 · 142 citations · Full text

, , +18

Efficacy and safety of canagliflozin in combination with insulin: a double-blind, randomized, placebo-controlled study in Japanese patients with type 2 diabetes mellitus

Nobuya Inagaki, Shin‐ichi Harashima, Nobuko Maruyama et al. · Cardiovascular Diabetology · 2016 · 69 citations · Full text

Intra‐ and inter‐subject variability for increases in serum ketone bodies in patients with type 2 diabetes treated with the sodium glucose co‐transporter 2 inhibitor canagliflozin

David Polidori, Hiroaki Iijima, Maki Goda et al. · Diabetes Obesity and Metabolism · 2018 · 62 citations · Full text

Safety and efficacy of canagliflozin in elderly patients with type 2 diabetes mellitus: a 1-year post-marketing surveillance in Japan

Maki Goda, Tomoko Yamakura, Kazuyo Sasaki et al. · Current Medical Research and Opinion · 2017 · 31 citations · Full text

Effects of Baseline Blood Pressure and Low-Density Lipoprotein Cholesterol on Safety and Efficacy of Canagliflozin in Japanese Patients with Type 2 Diabetes Mellitus

Nobuya Inagaki, Maki Goda, Shoko Yokota et al. · Advances in Therapy · 2015 · 24 citations · Full text

Rows per page

1–5 of 6